Showing results (81-90 of 98) with videos related to

Sort By:
Pageof 10
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 6, 2014
Combining gemcitabine, cisplatin, and ifosfamide (GIP) is active in patients with relapsed metastatic germ-cell tumors (GCT): a prospective multicenter GETUG phase II trialK Fizazi, G Gravis, A Flechon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 25, 2003
Results of randomised phase II studies comparing S16020 with methotrexate in patients with recurrent head and neck cancerX Pivot, A Awada, D Gedouin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 25, 2015
First-line treatment with sunitinib for type 1 and type 2 locally advanced or metastatic papillary renal cell carcinoma: a phase II study (SUPAP) by the French Genitourinary Group (GETUG)†A Ravaud, S Oudard, M De Fromont, et al.
The British Journal of Nutrition|March 14, 2007
Central adiposity in Brazilian schoolchildren aged 7-10 yearsM A A de Assis, M F Rolland-Cachera, F A G de Vasconcelos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 3, 1998
An EORTC-ECSG phase II study of vinorelbine in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neckM Degardin, J Oliveira, L Geoffrois, et al.
European Journal of Clinical Nutrition|June 23, 2005
Obesity, overweight and thinness in schoolchildren of the city of Florianópolis, Southern BrazilM A A de Assis, M F Rolland-Cachera, S Grosseman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 4, 2001
Phase II study of vinorelbine in patients with androgen-independent prostate cancerS Oudard, A Caty, Y Humblet, et al.
Pageof 10